Patient info

Etoricoxib 60 mg film-coated tablets – patient leaflet, side effects, dosage

Updated:
Key facts
Status:
Prescription only (POM)
Medicine strength:
60 mg
Contains active substance:
ATC code:

Patient leaflet - Etoricoxib 60 mg film-coated tablets

What Etoricoxib is and what it is used for

What is Etoricoxib?

  • Etoricoxib contains the active substance

    etoricoxib. Etoricoxib is one of a group of

    medicines called selective COX-2 inhibitors.

    These belong to a family of medicines

    called non-steroidal anti-inflammatory

    drugs (NSAIDs).

What is Etoricoxib used for?

  • Etoricoxib helps to reduce the pain and

    swelling (inflammation) in the joints and

    muscles of people 16 years of age and

    older with osteoarthritis, rheumatoid

    arthritis, ankylosing spondylitis and gout.

  • Etoricoxib is also used for the short term

    treatment of moderate pain after dental

    surgery in people 16 years of age and older.

What is osteoarthritis?

Osteoarthritis is a disease of the joints. It

results from the gradual breakdown of

cartilage that cushions the ends of the bones.

This causes swelling (inflammation), pain,

tenderness, stiffness and disability.

What is rheumatoid arthritis?

Rheumatoid arthritis is a long term inflammatory

disease of the joints. It causes pain, stiffness,

swelling, and increasing loss of movement in

the joints it affects. It may also cause

inflammation in other areas of the body.

What is gout?

Gout is a disease of sudden, recurring attacks

of very painful inflammation and redness in

the joints. It is caused by deposits of mineral

crystals in the joint.

What is ankylosing spondylitis?

Ankylosing spondylitis is an inflammatory

disease of the spine and large joints.

What you need to know before you take Etoricoxib

Do not take Etoricoxib if:

  • you are allergic to etoricoxib or any of the

    other ingredients of this medicine (listed in

    section 6)

  • you are allergic to non-steroidal

    anti-inflammatory drugs (NSAIDs), including

    acetylsalicylic acid (aspirin) and COX-2

    inhibitors (see Possible Side Effects, section 4)

  • you have a current stomach ulcer or

    bleeding in your stomach or intestines

  • you have serious liver disease
  • you have serious kidney disease
  • you are or could be pregnant or are

    breast-feeding (see ‘Pregnancy,

    breast-feeding and fertility’)

  • you are under 16 years of age
  • you have inflammatory bowel disease, such

    as Crohn’s Disease, Ulcerative Colitis, or

    Colitis

  • you have high blood pressure that has not

    been controlled by treatment (check with

    your doctor or nurse if you are not sure

    whether your blood pressure is adequately

    controlled)

  • your doctor has diagnosed heart problems

    including heart failure (moderate or severe

    types), angina (chest pain)

  • you have had a heart attack, bypass

    surgery, peripheral arterial disease (poor

    circulation in legs or feet due to narrow or

    blocked arteries)

  • you had any kind of stroke (including

    mini-stroke, transient ischaemic attack or

    TIA). Etoricoxib may slightly increase your

    risk of heart attack and stroke and this is

    why it should not be used in those who

    have already had heart problems or stroke.

If you think any of these are relevant to you,

do not take the tablets until you have

consulted your doctor.

Warnings and precautions

Talk to your doctor or pharmacist before

taking Etoricoxib if you:

  • have a history of stomach bleeding or ulcers
  • are dehydrated, for example by a

    prolonged bout of vomiting or diarrhoea

  • have swelling due to fluid retention
  • have a history of heart failure, or any other

    form of heart disease

  • have a history of high blood pressure.

    Etoricoxib can increase blood pressure in

    some people, especially in high doses, and

    your doctor will want to check your blood

    pressure from time to time

  • have any history of liver or kidney disease
  • are being treated for an infection.

    Etoricoxib can mask or hide a fever, which

    is a sign of infection

    • have diabetes, high cholesterol, or are a smoker. These can increase your risk of heart disease
    • are a woman trying to become pregnant
    • are over 65 years of age.

If you are not sure if any of the above apply to you, talk to your doctor before taking Etoricoxib to see if this medicine is suitable for you.

Etoricoxib works equally well in elderly and younger adult patients. If you are over 65 years of age, your doctor will want to appropriately keep a check on you. No dose adjustment is necessary for patients over 65 years of age. Children and adolescents

Do not give this medicine to children and adolescents under 16 years of age. Other medicines and Etoricoxib

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription.

In particular if you are taking any of the following medicines, your doctor may want to monitor you to check that your medicines are working properly, once you start taking Etoricoxib:

  • medicines that thin your blood

    (anticoagulants), such as warfarin

  • rifampicin (an antibiotic)
  • methotrexate (a medicine used for suppressing the immune system, and often used in rheumatoid arthritis)
  • ciclosporin or tacrolimus (medicines used for suppressing the immune system)
  • lithium (a medicine used to treat some types of depression)
  • medicines used to help control high blood pressure and heart failure called ACE inhibitors and angiotensin receptor blockers, examples include enalapril and ramipril, and losartan and valsartan
  • diuretics (water tablets)
  • digoxin (a medicine for heart failure and irregular heart rhythm)
  • minoxidil (a medicine used to treat high blood pressure)
  • salbutamol tablets or oral solution (a medicine for asthma)
  • birth control pills (the combination may increase your risk of side effects)
  • hormone replacement therapy (the combination may increase your risk of side effects)
  • acetylsalicylic acid (aspirin), the risk of stomach ulcers is greater if you take Etoricoxib with acetylsalicylic acid

    • acetylsalicylic acid for prevention of heart attacks or stroke:

      • Etoricoxib can be taken with low-dose acetylsalicylic acid. If you are currently taking low-dose acetylsalicylic acid to prevent heart attacks or stroke, you should not stop taking acetylsalicylic acid until you talk to your doctor.
    • acetylsalicylic acid and other non-steroidal anti-inflammatory drugs (NSAIDs):

      • do not take high dose acetylsalicylic acid or other anti-inflammatory medicines while taking Etoricoxib. Pregnancy, breast-feeding and fertility Pregnancy

Etoricoxib must not be taken during pregnancy. If you are pregnant or think you could be pregnant, or if you are planning to become pregnant, do not take the tablets. If you become pregnant, stop taking the tablets and consult your doctor. Consult your doctor if you are unsure or need more advice. Breast-feeding

It is not known if etoricoxib is excreted in human milk. If you are breast-feeding, or planning to breast-feed, consult your doctor before taking Etoricoxib. If you are using Etoricoxib, you must not breast-feed. Fertility

Etoricoxib is not recommended in women attempting to become pregnant.

Driving and using machines

Dizziness and sleepiness have been reported in some patients taking Etoricoxib. Do not drive if you experience dizziness or sleepiness.

Do not use any tools or machines if you experience dizziness or sleepiness.

How to take Etoricoxib

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. There are different strengths available for this medicinal product and depending on your disease your doctor will prescribe the tablet strength that is appropriate for you. The recommended dose is:

Osteoarthritis

The recommended dose is 30 mg once a day, increased to a maximum of 60 mg once a day if needed.

Rheumatoid arthritis

The recommended dose is 60 mg once a day, increased to a maximum of 90 mg once a day if needed.

Ankylosing spondylitis

The recommended dose is 60 mg once a day, increased to a maximum of 90 mg once a day if needed.

Acute pain conditions

Etoricoxib should be used only for the acute painful period.

Gout

The recommended dose is 120 mg once a day which should only be used for the acute painful period, limited to a maximum of 8 days treatment.

1

2

3

What is in this leaflet:

Package leaflet: Information for the user

BLACK Template

IMPORTANT: Artwork, text and content must not be reset, remade, amended or altered. The only exceptions to this are: bleeds, chokes, spreads or other print related adjustments required for reproduction by the supplier. We must receive a copy of any 3rd Party Supplier’s Proof before approval to print will be granted.

SKU (s): 273822 273823

273824 273826

(excluding codes)

Perforated: Univers. 9 pt TevaArt Ref: PID: 182567_s1 P: Etoricoxib UK Film-coated Tablet 30mg 60mg 90mg 120mg 28 DEB 13 June 2024

Version: 1

Length:

Width:

Depth:

460 mm

160 mm

-

Postoperative dental surgery pain

The recommended dose is 90 mg once daily, limited to a maximum of 3 days treatment. People with liver problems

  • if you have mild liver disease, you should not take more than 60 mg a day
  • if you have moderate liver disease, you should not take more than 30 mg a day. Do not take more than the recommended dose for your condition. Your doctor will want to discuss your treatment from time to time. It is important that you use the lowest dose that controls your pain and you should not take Etoricoxib for longer than necessary. This is because the risk of heart attacks and strokes might increase after prolonged treatment, especially with high doses. Use in children and adolescents

Etoricoxib should not be taken by children or adolescents under 16 years of age. Elderly

No dose adjustment is necessary for elderly patients. As with other medicines, caution should be exercised in elderly patients. Method of administration

Etoricoxib is for oral use.

Take tablets once a day. Etoricoxib can be taken with or without food.

If you take more Etoricoxib than you should

You should never take more tablets than the doctor recommends. If you do take too many Etoricoxib tablets, you should seek medical attention immediately.

If you forget to take Etoricoxib

It is important to take Etoricoxib as your doctor has prescribed. If you miss a dose, just resume your usual schedule the following day. Do not take a double dose to make up for the forgotten tablet.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. If you develop any of these signs you should stop Etoricoxib and talk to your doctor immediately (see What you need to know before you take Etoricoxib section 2):

  • shortness of breath, chest pains, or ankle swelling appear or if they get worse
  • yellowing of the skin and eyes (jaundice) – these are signs of liver problems
  • severe or continual stomach pain or your stools become black
  • an allergic reaction- which can include skin problems such as ulcers or blistering, or swelling of the face, lips, tongue, or throat which may cause difficulty in breathing. The following side effects can occur during treatment with Etoricoxib:

Very common: may affect more than 1 in 10 people

  • stomach pain.

Common: may affect up to 1 to 10 people

  • dry socket (inflammation and pain after tooth extraction)
  • swelling of the legs and/or feet due to fluid retention (oedema)
  • dizziness, headache
  • palpitations (fast or irregular heartbeat), irregular heart rhythm (arrhythmia),
  • increased blood pressure
  • wheezing or shortness of breath (bronchospasms)
  • constipation, wind (excessive gas), gastritis (inflammation of the lining of the stomach), heartburn, diarrhoea, indigestion (dyspepsia)/stomach discomfort, nausea, being sick (vomiting), inflammation of the oesophagus, mouth ulcers
  • changes in blood tests related to your liver
  • bruising
  • weakness and fatigue, flu-like illness. Uncommon: may affect up to 1 to 100 people
  • gastroenteritis (inflammation of the gastrointestinal tract that involves both the stomach and small intestine/stomach flu), upper respiratory infection, urinary tract infection
  • changes in laboratory values (decreased number of red blood cells, decreased number of white blood cells, platelets decreased)
  • hypersensitivity (an allergic reaction including hives which may be serious enough to require immediate medical attention)
  • appetite increases or decreases, weight gain
  • anxiety, depression, decreases in mental sharpness; seeing, feeling or hearing things that are not there (hallucinations)
  • taste alteration, inability to sleep, numbness or tingling, sleepiness
  • blurred vision, eye irritation and redness
  • ringing in the ears, vertigo (sensation of spinning while remaining still)
  • abnormal heart rhythm (atrial fibrillation), fast heart rate, heart failure, feeling of tightness, pressure or heaviness in the chest (angina pectoris), heart attack
  • flushing, stroke, mini-stroke (transient ischaemic attack), severe increase in blood pressure. Inflammation of the blood vessels
  • cough, breathlessness, nose bleed
  • stomach or bowel bloating, changes in your bowel habits, dry mouth, stomach ulcer, inflammation of the stomach lining that can become serious and may lead to bleeding, irritable bowel syndrome, inflammation of the pancreas
  • swelling of the face, skin rash or itchy skin, redness of the skin
  • muscle cramp/spasm, muscle pain/stiffness
  • high levels of potassium in your blood, changes in blood or urine tests relating to your kidney, serious kidney problems
  • chest pain.

    Rare: may affect up to 1 in 1, 000 people

    • angioedema (an allergic reaction with swelling of the face, lips, tongue and/or throat which may cause difficulty in breathing or swallowing, which may be serious enough to require immediate medical attention)/anaphylactic/anapylactoid reactions including shock (a serious allergic reaction that requires immediate medical attention)
    • confusion, restlessness
    • liver problems (hepatitis)
    • low blood levels of sodium
    • liver failure, yellowing of the skin and/or eyes (jaundice)
    • severe skin reactions.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme Website:

www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

By reporting side effects you can help provide more information on the safety of this medicine.

How to store Etoricoxib

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date refers to the last day of the month.

Store in the original package in order to protect from light.

Do not use this medicine if you notice visible signs of deterioration.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.

Contents of the pack and other information

What Etoricoxib contains

  • The active substance is etoricoxib. Each 30 mg film-coated tablet contains 30 mg of etoricoxib.

    Each 60 mg film-coated tablet contains 60 mg of etoricoxib.

    Each 90 mg film-coated tablet contains 90 mg of etoricoxib.

    Each 120 mg film-coated tablet contains 120 mg of etoricoxib.

  • The other ingredients are:

    Core: calcium hydrogen phosphate, Crospovidone (type A), Cellulose microcrystalline, Povidone K25, magnesium stearate.

    Tablet coating: Hypromellose,

    Hydroxypropylcellulose, Talc, Triglyceride medium chain, Titanium dioxide (E171), Cellulose microcrystalline (30 mg), Iron oxide red (30 mg) (E172), Indigo Carmine Al-lake (30, 60 & 120 mg) (E132), Brilliant blue Al-lake (60 & 120 mg) (E133), Iron oxide yellow (60 & 120 mg) (E172), Iron oxide black (60 & 120 mg) (E172). What Etoricoxib looks like and contents of the pack

30 mg: blue, round biconvex film-coated tablet, debossed "30" on one side and plain on the other.

60 mg: dark green, round biconvex film-coated tablet, debossed "60" on one side and plain on the other.

90 mg: white, round biconvex film-coated tablet, debossed "90" on one side and plain on the other.

120 mg: pale-green, round biconvex film-coated tablet, debossed "120" on one side and plain on the other.

Pack sizes:

30 mg: OPA/Al/PVC / Al blisters in packs or unit dose blisters containing 7, 14, 28, 28x1, 30, 98 film-coated tablets.

60 mg: OPA/Al/PVC / Al blisters in packs containing 7, 14, 20, 28, 28x1, 30, 50, 98, 100 film-coated tablets.

90 mg: OPA/Al/PVC / Al blisters in packs containing 5, 7, 7x1, 14, 20, 28, 28x1, 30, 50, 98, 100 film-coated tablets.

120 mg: OPA/Al/PVC / Al blisters in packs containing 5, 7, 7x1, 14, 16, 20, 28, 28x1, 30 film-coated tablets.

Not all pack sizes may be marketed. Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder

Teva UK Limited, Ridings Point, Whistler Drive, Castleford, WF10 5HX, United Kingdom Manufacturer

TEVA Gyógyszergyár Zrt., Debrecen, Pallagi út 13, H-4042, Hungary

This leaflet was last revised in 07/2024.

PL 00289/1934-1937

4

5

6

182567_s1

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 00289/1935

Last revision stated in the text: July 2024 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Etoricoxib 60 mg film-coated tablets

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Etoricoxib
Strength 60 mg
Pharmaceutical form Oral tablet
60mg Tablets: Green, round, diameter 8.00mm±0.2mm, biconvex, film-coated tablets debossed with “444” on one side and “L” on the other side.
How is it taken Oral
Excipients Calcium Phosphate dibasic Anhydrous Microcrystalline cellulose, Croscarmellose Sodium, Hydroxypropyl Cellulose, Magnesium Stearate, Hypromellose, Lactose Monohydrate,, Titanium Dioxide (E171),, Triacetin,, Indigo Carmine Aluminum Lake (E132) Iron Oxide Yellow (E172)
Pack sizes 28 tablet
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life Bottles: 2 years
Blisters: 3 years
Storage Bottles: Keep the bottle tightly closed in order to protect from moisture.
Blisters: Store in the original package in order to protect from moisture.
Drug group (ATC) Anti-inflammatory and antirheumatic products, non-steroids, coxibs
  1. M Musculo-skeletal system drugs
    1. M01 Antiinflammatory and antirheumatic products
      1. M01A Antiinflammatory and antirheumatic products, non-steroids
        1. M01AH Coxibs
          1. M01AH05 etoricoxib
Marketing authorisation PL 00289/1935, PL 36687/0211 (first authorised 29 January 2021)
Marketing authorisation holder Torrent Pharma (UK) Ltd.
Codes GTIN 5017007027584 · BNF 10010100

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.